Lite Strategy, Inc. Increase (Decrease) in Due to Related Parties, Current
Lite Strategy, Inc. (LITS) reported Increase (Decrease) in Due to Related Parties, Current of -$301.00 thousand for the 12-month period ending 2011-06-30, per its 10-K filed 2012-09-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent · last filed 2012-09-18
- Lite Strategy, Inc. increase (decrease) in due to related parties, current for the quarter ending 2011-06-30 was $0.00.
- Lite Strategy, Inc. increase (decrease) in due to related parties, current for the quarter ending 2011-03-31 was -$452.00K.
- Lite Strategy, Inc. increase (decrease) in due to related parties, current for the quarter ending 2010-12-31 was $178.00K.
- Lite Strategy, Inc. increase (decrease) in due to related parties, current for the quarter ending 2010-09-30 was -$27.00K.
- Lite Strategy, Inc. increase (decrease) in due to related parties, current for fiscal 2011 was -$301.00K.
| Period end | Increase (Decrease) in Due to Related Parties, Current 3 month | Increase (Decrease) in Due to Related Parties, Current 6 month | Increase (Decrease) in Due to Related Parties, Current 9 month | Increase (Decrease) in Due to Related Parties, Current 12 month |
|---|---|---|---|---|
| 2011-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-18 | -$452.00K derived: sum of 2 quarters · filed 2012-09-18 | -$274.00K derived: sum of 3 quarters · filed 2012-09-18 | -$301.00K 10-K · filed 2012-09-18 |
| 2011-03-31 | -$452.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-15 | -$274.00K derived: sum of 2 quarters · filed 2012-05-15 | -$301.00K 10-Q · filed 2012-05-15 | |
| 2010-12-31 | $178.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-09 | $151.00K 10-Q · filed 2012-02-09 | ||
| 2010-09-30 | -$27.00K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |